Short Float History | News | Indicators | Short Stats | Earnings History | Technical Averages | CLVS Yahoo Finance Page

CLVS Clovis Oncology Inc.

Note: We have detected that our data provider shows 0 for short interest. Please manually confirm and if different, disregard the short data and short pain data below.

$16.73 +8.36%

3,877,169 Shares Traded
3,227,164 Average Volume (last 30 days)

as of 3:59:59 PM EST IEX Real-Time Price

Click Here to Short Float History Versus Price & Peer Short Floats

Free Newsletter Sign Up

News

11-16-2018
Puma Biotechnology: Risky Investment (SeekingAlpha)
11-12-2018
Biotechs getting slammed again, XBI down almost 4% (SeekingAlpha)


Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $0
If Intiated on the First, Shorts Have Realized a Year to Date Return of:76.62%
If Intiated One Month Ago, Shorts Have Realized a Return of:44.54%
If Initiated Five Days ago, Shorts Have Realized a Return of:1.34%
Peer Rising Stocks Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 0%
Short Interest0
Float51.29 million
Short Ratio0
Market Cap$813.87 million
Market Maker ActivityDaily Short Volume

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 157.2%

Earnings Stats

PE Ratio -2.59
Dividend Yield 0%

Earnings History For CLVS

Earnings DateQuarterConsensus EPSActual EPSEPS Surprise
2018-10-30 AMCQ3 2018-1.6 (6 Estimates) -1.71-0.11
2018-08-01 AMCQ2 2018-1.38 (4 Estimates) -1.94-0.56
2018-05-08 AMCQ1 2018-1.34 (5 Estimates) -1.54-0.2
2018-02-26 AMCQ4 2017-1.28 (7 Estimates) -1.270.01

Technicals

200 Day Moving Average $42.62
50 Day Moving Average $25.36
52 Week High $69.02
52 Week Low $11.5

Back to the Top

Data provided for free by IEX. Questions? Read the FAQ